Dake Benjamin T's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Nov 27, 2023
- Accession no.
- 0001415889-23-015509
- Filed
- Nov 27, 2023
- Trade date
- Nov 22-24, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 6 derivative transactions. Open-market sales total $220.9K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dake Benjamin TCIK 0001869248 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 | Common Stock | MOption exerciseAcquired | +2,412 | $1.74 | +$4,196.88 | 3,703 | Direct | |
| Nov 22, 2023 | Common Stock | MOption exerciseAcquired | +6,970 | $2.14 | +$14,915.8 | 10,673 | Direct | |
| Nov 22, 2023 | Common Stock | SSaleDisposed | −9,382 | $15.17 | −$142,324.94 | 1,291 | Direct | |
| Nov 24, 2023 | Common Stock | MOption exerciseAcquired | +4,990 | $2.14 | +$10,678.6 | 6,281 | Direct | |
| Nov 24, 2023 | Common Stock | SSaleDisposed | −4,920 | $15.74 | −$77,440.8 | 1,361 | Direct | |
| Nov 24, 2023 | Common Stock | SSaleDisposed | −70 | $16.07 | −$1,124.9 | 1,291 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 | Common Stock | MOption exerciseDisposed | −905 | $0.00 | $0 | 2,717 | Direct | |
| Nov 22, 2023 | Common Stock | MOption exerciseDisposed | −1,507 | $0.00 | $0 | 15,068 | Direct | |
| Nov 22, 2023 | Common Stock | MOption exerciseDisposed | −648 | $0.00 | $0 | 18,702 | Direct | |
| Nov 22, 2023 | Common Stock | MOption exerciseDisposed | −6,322 | $0.00 | $0 | 143,904 | Direct | |
| Nov 24, 2023 | Common Stock | MOption exerciseDisposed | −371 | $0.00 | $0 | 18,331 | Direct | |
| Nov 24, 2023 | Common Stock | MOption exerciseDisposed | −4,619 | $0.00 | $0 | 139,285 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.